Barclays’s UnitedHealth UNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $77M | Sell |
284,700
-7,600
| -3% | -$2.26M | 0.02% | 586 |
|
|
2025
Q4 | $96.5M | Sell |
292,300
-2,400
| -0.8% | -$813K | 0.02% | 521 |
|
|
2025
Q3 | $102M | Sell |
294,700
-305,200
| -51% | -$92.3M | 0.02% | 490 |
|
|
2025
Q2 | $187M | Buy |
599,900
+594,900
| +11,898% | +$227M | 0.04% | 287 |
|
|
2025
Q1 | $2.62M | Sell |
5,000
-2,200
| -31% | -$1.12M | ﹤0.01% | 2428 |
|
|
2024
Q4 | $3.64M | Hold |
7,200
| – | – | ﹤0.01% | 2432 |
|
|
2024
Q3 | $4.21M | Sell |
7,200
-85,600
| -92% | -$48.4M | ﹤0.01% | 2238 |
|
|
2024
Q2 | $47.3M | Buy |
92,800
+57,400
| +162% | +$28.1M | 0.01% | 638 |
|
|
2024
Q1 | $17.5M | Sell |
35,400
-800
| -2% | -$407K | 0.01% | 1058 |
|
|
2023
Q4 | $19.1M | Buy |
+36,200
| New | +$19.3M | 0.01% | 1079 |
|
|
2023
Q2 | – | Sell |
-83,000
| Closed | -$39.2M | – | 5093 |
|
|
2023
Q1 | $39.2M | Sell |
83,000
-48,500
| -37% | -$23.4M | 0.02% | 574 |
|
|
2022
Q4 | $69.7M | Buy |
+131,500
| New | +$69.7M | 0.03% | 357 |
|
|
2022
Q3 | – | Sell |
-6,000
| Closed | -$3.08M | – | 5152 |
|
|
2022
Q2 | $3.08M | Buy |
+6,000
| New | +$3.01M | ﹤0.01% | 1583 |
|
|
2021
Q4 | – | Sell |
-19,600
| Closed | -$7.66M | – | 4751 |
|
|
2021
Q3 | $7.66M | Buy |
+19,600
| New | +$8.12M | ﹤0.01% | 1344 |
|
|
2021
Q2 | – | Sell |
-10,000
| Closed | -$3.72M | – | 5089 |
|
|
2021
Q1 | $3.72M | Sell |
10,000
-63,200
| -86% | -$21.9M | ﹤0.01% | 1767 |
|
|
2020
Q4 | $25.7M | Hold |
73,200
| – | – | 0.01% | 726 |
|
|
2020
Q3 | $22.8M | Sell |
73,200
-5,600
| -7% | -$1.72M | 0.01% | 693 |
|
|
2020
Q2 | $23.2M | Sell |
78,800
-35,100
| -31% | -$10.1M | 0.02% | 584 |
|
|
2020
Q1 | $28.4M | Sell |
113,900
-9,700
| -8% | -$2.67M | 0.02% | 502 |
|
|
2019
Q4 | $36.3M | Sell |
123,600
-23,900
| -16% | -$6.25M | 0.02% | 647 |
|
|
2019
Q3 | $32.1M | Sell |
147,500
-11,100
| -7% | -$2.68M | 0.02% | 636 |
|
|
2019
Q2 | $38.7M | Buy |
158,600
+5,900
| +4% | +$1.42M | 0.02% | 579 |
|
|
2019
Q1 | $37.8M | Buy |
152,700
+31,200
| +26% | +$7.96M | 0.03% | 537 |
|
|
2018
Q4 | $30.3M | Buy |
121,500
+9,700
| +9% | +$2.56M | 0.02% | 556 |
|
|
2018
Q3 | $29.7M | Sell |
111,800
-15,600
| -12% | -$4.06M | 0.02% | 651 |
|
|
2018
Q2 | $31.3M | Buy |
127,400
+78,800
| +162% | +$18.9M | 0.03% | 564 |
|
|
2018
Q1 | $10.4M | Buy |
48,600
+16,100
| +50% | +$3.68M | 0.01% | 1159 |
|
|
2017
Q4 | $7.17M | Sell |
32,500
-7,800
| -19% | -$1.65M | 0.01% | 1394 |
|
|
2017
Q3 | $7.89M | Sell |
40,300
-40,300
| -50% | -$7.79M | 0.01% | 1192 |
|
|
2017
Q2 | $14.9M | Buy |
80,600
+46,300
| +135% | +$8.12M | 0.02% | 749 |
|
|
2017
Q1 | $5.63M | Sell |
34,300
-191,600
| -85% | -$31.4M | 0.01% | 1249 |
|
|
2016
Q4 | $36.2M | Sell |
225,900
-79,600
| -26% | -$11.9M | 0.04% | 358 |
|
|
2016
Q3 | $42.8M | Buy |
305,500
+208,200
| +214% | +$29.2M | 0.05% | 292 |
|
|
2016
Q2 | $13.7M | Buy |
97,300
+13,700
| +16% | +$1.83M | 0.02% | 683 |
|
|
2016
Q1 | $10.7M | Sell |
83,600
-30,600
| -27% | -$3.62M | 0.02% | 736 |
|
|
2015
Q4 | $13.4M | Sell |
114,200
-127,400
| -53% | -$14.9M | 0.02% | 749 |
|
|
2015
Q3 | $28M | Buy |
241,600
+150,000
| +164% | +$18M | 0.03% | 446 |
|
|
2015
Q2 | $11.2M | Sell |
91,600
-164,200
| -64% | -$19.4M | 0.01% | 967 |
|
|
2015
Q1 | $30.2M | Buy |
255,800
+110,700
| +76% | +$12.3M | 0.03% | 501 |
|
|
2014
Q4 | $14.7M | Sell |
145,100
-568,100
| -80% | -$53.8M | 0.01% | 938 |
|
|
2014
Q3 | $61.3M | Sell |
713,200
-327,800
| -31% | -$27.7M | 0.06% | 263 |
|
|
2014
Q2 | $84.3M | Buy |
1,041,000
+575,700
| +124% | +$45.3M | 0.09% | 178 |
|
|
2014
Q1 | $37.7M | Buy |
465,300
+224,200
| +93% | +$16.9M | 0.04% | 385 |
|
|
2013
Q4 | $18.1M | Buy |
241,100
+61,800
| +34% | +$4.44M | 0.02% | 821 |
|
|
2013
Q3 | $12.7M | Sell |
179,300
-85,300
| -32% | -$6.1M | 0.02% | 966 |
|
|
2013
Q2 | $17.3M | Buy |
+264,600
| New | +$16.5M | 0.02% | 723 |
|
Other funds holding UNH
VCM
VPM
Barclays's UNH Position: Q1 2026 in Review
Barclays reduced its UnitedHealth (UNH) stake by 14% in Q1 2026, selling an estimated $136M and leaving 2,817,725 shares worth $762M. The position accounts for 0.18% of the portfolio, ranked #79.
Barclays first reported a position in UNH in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.23B in Q1 2025. 3,020 funds tracked by Wall St. Rank hold UNH as of Q1 2026.
- Barclays held 2,817,725 shares of UnitedHealth worth $762M as of Q1 2026.
- Barclays sold 456,917 UnitedHealth shares in Q1 2026, an estimated $136M.
- UnitedHealth made up 0.18% of Barclays's portfolio in Q1 2026, its #79 holding.
- Barclays first reported a position in UnitedHealth in Q2 2013 and has held it in 52 quarters since.
- Barclays's UnitedHealth position peaked at $2.23B in Q1 2025.
- 3,020 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.